GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.500 $0.720 Friday, 19th Apr 2024 ADXS stock ended at $0.572. This is 0.351% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.90% from a day low at $0.572 to a day high of $0.600.
90 days $0.500 $1.49
52 weeks $0.500 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
2024-02-07 $1.31 $1.32 $1.09 $1.14 88 960
2024-02-06 $0.92 $1.49 $0.90 $1.31 480 276
2024-02-05 $0.532 $0.590 $0.520 $0.590 16 768
2024-02-02 $0.550 $0.600 $0.549 $0.549 6 341
2024-02-01 $0.550 $0.625 $0.550 $0.580 8 463
2024-01-31 $0.532 $0.555 $0.532 $0.552 5 346
2024-01-30 $0.520 $0.532 $0.520 $0.532 2 597
2024-01-29 $0.600 $0.610 $0.511 $0.520 23 301
2024-01-26 $0.620 $0.639 $0.580 $0.600 2 704
2024-01-25 $0.605 $0.605 $0.560 $0.570 1 109
2024-01-24 $0.571 $0.670 $0.570 $0.600 28 130
2024-01-23 $0.600 $0.620 $0.571 $0.590 8 505
2024-01-22 $0.570 $0.687 $0.570 $0.600 7 163
2024-01-19 $0.570 $0.614 $0.570 $0.614 1 436
2024-01-18 $0.600 $0.601 $0.583 $0.601 3 363
2024-01-17 $0.600 $0.635 $0.600 $0.600 615
2024-01-16 $0.620 $0.680 $0.600 $0.680 41 146
2024-01-12 $0.687 $0.687 $0.570 $0.571 1 486
2024-01-11 $0.600 $0.602 $0.600 $0.600 1 051
2024-01-10 $0.650 $0.650 $0.591 $0.625 1 587
2024-01-09 $0.601 $0.662 $0.601 $0.650 9 850
2024-01-08 $0.590 $0.618 $0.588 $0.593 11 915
2024-01-05 $0.600 $0.600 $0.590 $0.590 58 139
2024-01-04 $0.623 $0.632 $0.590 $0.600 10 983
2024-01-03 $0.640 $0.642 $0.627 $0.627 27 009
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT